Literature DB >> 11159966

In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice.

Y R Freund1, N T Zaveri, H S Javitz.   

Abstract

Toxoplasmic encephalitis (TE) is a life-threatening disease of immunocompromised individuals and has increased in prevalence as a consequence of AIDS. TE has been modeled in inbred mice, with CBA/Ca mice being susceptible and BALB/c mice resistant to the development of TE. To better understand the innate mechanisms in the brain that play a role in resistance to TE, nitric oxide (NO)-dependent and NO-independent mechanisms were examined in microglia from BALB/c and CBA/Ca mice and correlated with the ability of these cells to inhibit Toxoplasma gondii replication. These parameters were measured 48 h after stimulation with lipopolysaccharide (LPS) gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), or combinations of these inducers in T. gondii-infected microglia isolated from newborn mice. CBA/Ca microglia consistently produced less NO than did BALB/c microglia after stimulation with LPS or with IFN-gamma plus TNF-alpha, and they inhibited T. gondii replication significantly less than did BALB/c microglia. Cells of both strains treated with IFN-gamma alone significantly inhibited uracil incorporation by T. gondii, and N(G)-monomethyl-L-arginine (NMMA) treatment did not reverse this effect. In cells treated with IFN-gamma in combination with other inducers, NMMA treatment resulted in only partial recovery of T. gondii replication. This IFN-gamma-dependent inhibition of replication was not due to generation of reactive oxygen species or to increased tryptophan degradation. These data suggest that NO production and an IFN-gamma-dependent mechanism contribute to the inhibition of T. gondii replication after in vitro stimulation with IFN-gamma plus TNF-alpha or with LPS. Differences in NO production but not in IFN-gamma-dependent inhibition of T. gondii replication were observed between CBA/Ca and BALB/c microglia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159966      PMCID: PMC97950          DOI: 10.1128/IAI.69.2.765-772.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.

Authors:  G S Yap; A Sher
Journal:  Immunobiology       Date:  1999-12       Impact factor: 3.144

2.  Adoptive immunity to intracellular infection.

Authors:  J K Frenkel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

3.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

4.  Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon.

Authors:  E R Pfefferkorn; P M Guyre
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.

Authors:  H W Murray; B Y Rubin; S M Carriero; A M Harris; E A Jaffee
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

6.  Induction of tumor necrosis factor-alpha and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-gamma in genetically resistant BALB/c mice.

Authors:  Y Suzuki; H Kang; S Parmley; S Lim; D Park
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

7.  New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

Authors:  D G Mack; R McLeod
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

8.  Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

Authors:  E R Pfefferkorn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.

Authors:  B J Luft; R Hafner; A H Korzun; C Leport; D Antoniskis; E M Bosler; D D Bourland; R Uttamchandani; J Fuhrer; J Jacobson
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  12 in total

1.  Dendritic cells as effector cells: gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication.

Authors:  F Aline; D Bout; I Dimier-Poisson
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 2.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

Review 3.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Sérgio Seabra; Celso Sant'anna; J Gabriel R Gonçalves; Marcelo Bozza; Vivaldo Moura-Neto; Wanderley De Souza
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

Review 5.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  Dectin-1-CD37 association regulates IL-6 expression during Toxoplasma gondii infection.

Authors:  Junping Yan; Bin Wu; Bo Huang; Shiguang Huang; Suhua Jiang; Fangli Lu
Journal:  Parasitol Res       Date:  2014-05-29       Impact factor: 2.289

7.  Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Rodrigo T Figueiredo; Marcelo T Bozza; Flávia R S Lima; Ana Lúcia Pires; Patrícia M Silva; Adriana Bonomo; Joseli Lannes-Vieira; Wanderley De Souza; Vivaldo Moura-Neto
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 8.  Microglia in infectious diseases of the central nervous system.

Authors:  Monica M Mariani; Tammy Kielian
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-02       Impact factor: 4.147

9.  Interferon gamma effect on immune mediator production in human nerve cells infected by two strains of Toxoplasma gondii.

Authors:  Nour Mammari; Philippe Vignoles; Mohamad Adnan Halabi; Marie-Laure Dardé; Bertrand Courtioux
Journal:  Parasite       Date:  2015-12-21       Impact factor: 3.000

10.  In vitro infection of human nervous cells by two strains of Toxoplasma gondii: a kinetic analysis of immune mediators and parasite multiplication.

Authors:  Nour Mammari; Philippe Vignoles; Mohamad Adnan Halabi; Marie Laure Darde; Bertrand Courtioux
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.